Medicure Stock Last Dividend Paid
MCUJF Stock | USD 0.70 0.02 2.94% |
Medicure fundamentals help investors to digest information that contributes to Medicure's financial success or failures. It also enables traders to predict the movement of Medicure Pink Sheet. The fundamental analysis module provides a way to measure Medicure's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medicure pink sheet.
Medicure |
Medicure Company Last Dividend Paid Analysis
Medicure's Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
Competition |
Based on the recorded statements, Medicure has a Last Dividend Paid of 0.0. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Cryptocurrency Center Now
Cryptocurrency CenterBuild and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |
All Next | Launch Module |
Medicure Fundamentals
Return On Equity | 0.15 | |||
Return On Asset | 0.021 | |||
Profit Margin | 0.12 % | |||
Operating Margin | 0.04 % | |||
Current Valuation | 5.67 M | |||
Shares Outstanding | 10.25 M | |||
Shares Owned By Insiders | 26.70 % | |||
Shares Owned By Institutions | 23.51 % | |||
Number Of Shares Shorted | 15.08 K | |||
Price To Earning | 11.45 X | |||
Price To Book | 0.57 X | |||
Price To Sales | 0.37 X | |||
Revenue | 21.74 M | |||
Gross Profit | 12.71 M | |||
EBITDA | 2.42 M | |||
Net Income | (727 K) | |||
Cash And Equivalents | 4.83 M | |||
Cash Per Share | 0.47 X | |||
Total Debt | 1.02 M | |||
Debt To Equity | 0.05 % | |||
Current Ratio | 1.47 X | |||
Book Value Per Share | 2.04 X | |||
Cash Flow From Operations | 3.99 M | |||
Short Ratio | 1.77 X | |||
Earnings Per Share | 0.21 X | |||
Price To Earnings To Growth | (23.59) X | |||
Target Price | 0.13 | |||
Number Of Employees | 12 | |||
Beta | 1.05 | |||
Market Capitalization | 9.24 M | |||
Total Asset | 28.41 M | |||
Retained Earnings | (89.95 M) | |||
Working Capital | 5.11 M | |||
Current Asset | 12.56 M | |||
Current Liabilities | 7.45 M | |||
Z Score | 1.2 | |||
Net Asset | 28.41 M |
About Medicure Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medicure's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medicure using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medicure based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Medicure Pink Sheet
Medicure financial ratios help investors to determine whether Medicure Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medicure with respect to the benefits of owning Medicure security.